摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+/-)-epivincadine

中文名称
——
中文别名
——
英文名称
(+/-)-epivincadine
英文别名
(+/-)-Epivincadin;methyl (13R,15R)-15-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate
(+/-)-epivincadine化学式
CAS
——
化学式
C21H28N2O2
mdl
——
分子量
340.466
InChiKey
JFLTVMWSBAMWAW-DYESRHJHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    25
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    45.3
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    (+)-vincadifformine 在 sodium tetrahydroborate 、 乙酸-2,2,2-D3 作用下, 以35%的产率得到(+/-)-epivincadine
    参考文献:
    名称:
    长春花生物碱及相关化合物的合成,第94部分。带有aspperospermane和D- secoaspidospermane骨架的化合物的差向异构体†
    摘要:
    研究了长春花蕾碱(1),去乙基长春花碱异构体(2,3),其合成中间体(4–13)以及具有D -secoaspidospermane骨架的较简单化合物的个别差向异构化步骤(15–17)a)在质子培养基中(在沸腾的氘代乙酸中)和(b)在还原条件下(在沸腾的乙酸中用硼氘化钠或在沸腾的氘代乙酸中用硼氢化钠)。
    DOI:
    10.1002/jhet.5570370205
点击查看最新优质反应信息

文献信息

  • Total syntheses of eburnamonine, quebrachamine, vincadine and epivincadine
    作者:Ernest Wenkert、Timothy D.J. Halls、Lawrence D. Kwart、Göran Magnusson、H.D.Hollis Showalter
    DOI:10.1016/s0040-4020(01)93276-4
    日期:——
    Syntheses of the alkaloids eburnamonine and quebrachamine are presented in which the non-tryptamine portion of the skeleta is constructed by the β-oxycyclopropylcarboxylate preparation-fragmentation route. A similar reaction scheme is utilized for the synthesis of the alkaloids vincadine and epivincadine.
    提出了生物碱金枪鱼碱和quebrachamine的合成,其中skeleta的非色胺部分是通过β-氧基环丙基羧酸酯制备-片段化路线构建的。类似的反应方案被用于合成长春碱和长春碱的生物碱。
  • Synthesis of vinca alkaloids and related compounds part 94. Epimerization of compounds with aspidospermane and<i>D</i>-secoaspidospermane skeleton
    作者:György Kalaus、Lajos Szabó、János Éles、Csaba Szántay、Imre Juhász、IstvÁn Greiner、János Brlik、Mária Kajtár-Peredy
    DOI:10.1002/jhet.5570370205
    日期:2000.3
    The individual epimerization steps of vincadifformine (1), deethylvincadifformine isomers (2,3), their synthetic intermediates (4–13) as well as that of simpler compounds with D-secoaspidospermane skeleton (15–17) were studied a) in protic medium (boiling deuteroacetic acidic) and b) under reductive (with sodium borodeuteride in boiling acetic acid, or with sodium borohydride in boiling deuteroacetic
    研究了长春花蕾碱(1),去乙基长春花碱异构体(2,3),其合成中间体(4–13)以及具有D -secoaspidospermane骨架的较简单化合物的个别差向异构化步骤(15–17)a)在质子培养基中(在沸腾的氘代乙酸中)和(b)在还原条件下(在沸腾的乙酸中用硼氘化钠或在沸腾的氘代乙酸中用硼氢化钠)。
查看更多

同类化合物

(1aR,13S,13aS)-13-乙基-1a,4,5,10,11,12,13,13a-八氢-2H-3,13-甲桥环氧乙烷并[9,10]氮杂环十一碳五烯并[5,4-b]吲哚 (-)-dehydroquebrachamine (-)-N-methylquebrachamine tetradehydro-(+)-quebrachamine (+)-14,15-didehydroquebrachamine quebrachamine 5,6,11,12-tetrahydro-4H,13aH-3a,13-propanofuro[3',2':8,9]azonino[5,4-b]indol-2(3H)-one oxoquebrachamine (+)-N-methylquebrachamine (+/-)-vincadine Vincaminoreine vincadine quebrachamine (+/-)-epivincadine 14,15,16,17-Dehydroquebrachamin (15S)-15-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,13,16-hexaene (15R)-15-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,13,16-hexaene 15-Ethyl-11-aza-1-azoniapentacyclo[13.3.1.01,13.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene 15-ethyl-11-aza-1-azoniapentacyclo[13.3.1.01,13.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene;magnesium(1+) monohydride;hydroxide 5,10-Dioxo-quebrachamin 15-Ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,13,16-hexaene methyl N-[(15-ethyl-2-oxo-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-ylidene)amino]carbamate 15-Ethyl-11,18-dimethyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraene 15-Ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-16,17-diol 15-Ethyl-11-methyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraen-13-ol (1aR,13S,13aS)-13-Ethyl-1a,4,5,10,11,12,13,13a-octahydro-10-methyl-2H-3,13-methanooxireno[9,10]azacycloundecino[5,4-b]indole 15-Ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraen-13-ol 15-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8-tetraen-19-ol 15-Ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-17-ol 17-Ethoxy-19-oxa-5,15-diazapentacyclo[13.6.1.01,18.04,12.06,11]docosa-4(12),6,8,10-tetraene Ervayunine 15-Ethyl-11-methyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-16,17-diol 15-Ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraen-2-ol 15-Ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraen-19-one Vincadin 15-Ethyl-13-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-19-one (±)-N-methylquebrachamine quebrachamine Methyl 17-ethyl-19-oxa-3,13-diazapentacyclo[15.2.1.02,10.04,9.013,18]icosa-2(10),4,6,8,15-pentaene-1-carboxylate 15-Ethyl-11-(methoxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene 9-Methoxy-quebrachamin dl-Vincaminorein Methyl 15-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene-13-carboxylate Methyl 15-ethyl-8-methoxy-11-methyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5(10),6,8-tetraene-13-carboxylate 13-Ethyl-9-methoxy-1a,4,5,10,11,12,13,13a-octahydro-2h-3,13-methanooxireno[9,10]azacycloundecino[5,4-b]indole 15-Ethyl-8-hydroxy-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5(10),6,8-tetraen-2-one